Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJust Group Regulatory News (JUST)

Share Price Information for Just Group (JUST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.00
Bid: 105.00
Ask: 105.40
Change: 1.00 (0.96%)
Spread: 0.40 (0.381%)
Open: 104.00
High: 105.20
Low: 104.00
Prev. Close: 104.00
JUST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Just Group notes publication of PRA PS 31/18

10 Dec 2018 07:20

RNS Number : 8936J
Just Group PLC
10 December 2018
 

 

 

 

 

 

NEWS RELEASE

www.justgroupplc.co.uk

10 December 2018

 

Prudential Regulation Authority publishes Policy Statement PS31/18 Solvency II: Equity release mortgages

 

Just Group plc ("Just", "the Group") notes Policy Statement 31/18 (the "Policy Statement") released by the Prudential Regulation Authority ("PRA") this morning, which sets out its conclusions on the treatment of equity release mortgages1 ("ERMs") being held to back annuity liabilities. The Policy Statement follows the three month consultation process after the release of Consultation Paper 13/18 - Solvency II: equity release mortgages ("the CP"), on 2 July 2018. Just Group particularly welcomes the PRA's confirmation that transitional relief will remain available for pre-2016 business.

 

Our interpretation of the Policy Statement is that the following key changes compared to the CP will apply in relation to the treatment of lifetime mortgages within the effective value test ("EVT"):

 

·

Transitional measures for technical provisions for pre-2016 business will be recognised over the remaining transitional period to 31 December 2031

·

Deferment rate will be 1%

·

Volatility will initially be set at 13%, towards the lower end of the range considered within the CP

·

The PRA has confirmed it has no plans to apply the EVT approach to other assets

 

The PRA has announced it intends to consult further in early 2019 on various matters, including the process by which the volatility and deferment rates will be reset and how the EVT applies in stress

 

As previously announced, the Group had already aligned new business pricing with the expected post-CP capital requirements. The Group's competitive advantages remain in place in its three core, structurally growing, retirement market segments: Defined Benefit de-risking, Guaranteed Income for Life and ERMs. Together, the growth in these markets supported a 44% increase in the Group's Retirement Income sales during the 9 months to 30 September 2018. Efficiency gains and the Group's focus on pricing discipline since the 2016 merger have enabled the Group to take advantage of these market conditions to expand new business margins from 3.3% in 2015 to 10.2% in the 6 months ended 30 June 2018.

 

The proposed new regime and an implementation date of 31 December 2019 mean the Board can adopt a considered approach to determining the optimal capital mix and level in order to provide a prudent base to support our new business franchise, and to establishing an appropriate dividend policy for shareholders. The Board is reviewing the strength of the balance sheet, and as set out in the Company's 2018 interim results presentation, has a range of capital options from which to choose in due course.

 

Rodney Cook, Group Chief Executive, said:

 

"We welcome the greater clarity provided by the Policy Statement, and the PRA's recognition of the important role played by ERMs for our customers as they plan their retirement finances. The regime envisaged is considerably less onerous for Just than set out in the CP, particularly in respect of pre Solvency II business, and the outcome is well within the range of what we have been planning for. However, even at the 13%/1% parameters confirmed today, we view the EVT as very prudent, as for JRL2 it is equivalent to holding capital and technical provisions sufficient for the price of every house in the portfolio to fall immediately by over 35% and then remain there indefinitely. The changes prescribed by the Policy Statement do not take effect until 31 December 2019. This means the Board can evaluate the optimal capital structure to support our new business franchise in a considered manner."

 

 

 

Note 1 ERMs are also sometimes known as Lifetime mortgages or LTMs

Note 2 "JRL" - Just Retirement Ltd

 

 

 

 

Enquiries

 

Investors / Analysts

 

James Pearce, Director of Group Finance

 

Telephone: +44 (0) 7715 085 099

james.pearce@wearejust.co.uk

 

Alistair Smith, Investor Relations Manager

Telephone: +44 (0) 1737 232 792

alistair.smith@wearejust.co.uk

 

 

 

Media

 

Stephen Lowe, Group Communications Director

 

Telephone: +44 (0) 1737 827 301

press.office@wearejust.co.uk

 

Temple Bar Advisory

Alex Child-Villiers +44 (0)7795 425 580

William Barker

Telephone: +44 (0) 20 7002 1080

 

 

FINANCIAL CALENDAR

 

DATE

Results for the year ended 31 December 2018

14 March 2019

 

 

A copy of this announcement will be available on the Group's website www.justgroupplc.co.uk

 

JUST GROUP PLC

GROUP COMMUNICATIONS

Vale House, Roebuck Close

Bancroft Road, Reigate

Surrey RH2 7RU

 

 

 

Forward-looking statements disclaimer:

 

This announcement in relation to Just Group plc and its subsidiaries (the "Group") contains, and we may make other statements (verbal or otherwise) containing, forward-looking statements about the Group's current plans, goals and expectations relating to future financial conditions, performance, results, strategy and/or objectives.

 

Statements containing the words: 'believes', 'intends', 'expects', 'plans', 'seeks', 'targets', 'continues' and 'anticipates' or other words of similar meaning are forward-looking (although their absence does not mean that a statement is not forward-looking). Forward-looking statements involve risk and uncertainty because they relate to future events and circumstances that are beyond the Group's control. For example, certain insurance risk disclosures are dependent on the Group's choices about assumptions and models, which by their nature are estimates. As such, although the Group believes its expectations are based on reasonable assumptions, actual future gains and losses could differ materially from those that we have estimated.

 

Other factors which could cause actual results to differ materially from those estimated by forward-looking statements include but are not limited to: domestic and global economic and business conditions; asset prices; market-related risks such as fluctuations in interest rates and exchange rates, and the performance of financial markets generally; the policies and actions of governmental and/or regulatory authorities including, for example, new government initiatives related to the provision of retirement benefits or the costs of social care; the impact of inflation and deflation; market competition; changes in assumptions in pricing and reserving for insurance business (particularly with regard to mortality and morbidity trends, gender pricing and lapse rates); risks associated with arrangements with third parties, including joint ventures and distribution partners; inability of reinsurers to meet obligations or unavailability of reinsurance coverage; the impact of changes in capital, solvency or accounting standards; and tax and other legislation and regulations in the jurisdictions in which the Group operates.

 

As a result, the Group's actual future financial condition, performance and results may differ materially from the plans, goals and expectations set out in the forward-looking statements within this announcement. The forward-looking statements only speak as at the date of this document and the Group undertakes no obligation to update or change any of the forward-looking statements contained within this announcement or any other forward-looking statements it may make. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAAANEEDPFAF
Date   Source Headline
7th May 20241:00 pmRNSResult of AGM
25th Apr 202410:04 amRNSDirector/PDMR Shareholding
12th Apr 202410:00 amRNSDirector/PDMR Shareholding
2nd Apr 20245:20 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSHolding(s) in Company
26th Mar 20244:08 pmRNSHolding(s) in Company
26th Mar 20243:41 pmRNSAnnual Report and Accounts and Notice of AGM
8th Mar 20247:00 amRNSResults for the year ended 31 December 2023
7th Mar 20244:00 pmRNSHolding(s) in Company
6th Mar 20244:00 pmRNSHolding(s) in Company
4th Mar 20244:30 pmRNSHolding(s) in Company
5th Feb 20245:00 pmRNSHolding(s) in Company
31st Jan 20243:30 pmRNSHolding(s) in Company
26th Jan 20241:49 pmRNSHolding(s) in Company
25th Jan 20245:30 pmRNSDirector Declaration
22nd Jan 20244:43 pmRNSHolding(s) in Company
18th Jan 20244:55 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSBUSINESS UPDATE FOR YEAR ENDED 31 DECEMBER 2023
17th Jan 20244:12 pmRNSHolding(s) in Company
12th Jan 20243:01 pmRNSHolding(s) in Company
10th Jan 20241:31 pmRNSHolding(s) in Company
4th Jan 20244:25 pmRNSHolding(s) in Company
1st Dec 202311:32 amRNSBlock listing Interim Review
28th Nov 20233:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20233:04 pmRNSDirectorate Change
13th Oct 202310:41 amRNSDirectorate Change
28th Sep 202310:13 amRNSDirector/PDMR Shareholding
16th Aug 20232:04 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS ENDED 30/6/2023
20th Jul 20233:00 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSBusiness update for the six months to 30 June 2023
12th Jul 202310:34 amRNSDirectorate Change
11th Jul 20237:00 amRNSIFRS 17 FY 2022 and H1 22 restatement
6th Jul 20237:00 amRNSDirectorate Change
28th Jun 20239:36 amRNSHolding(s) in Company
1st Jun 202310:00 amRNSBlock listing Interim Review
25th May 20234:00 pmRNSHolding(s) in Company
9th May 20231:02 pmRNSResult of AGM
3rd May 20239:30 amRNSDirectorate Change
13th Apr 202312:05 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:05 pmRNSDirector/PDMR Shareholding
24th Mar 20234:50 pmRNSAnnual Financial Report and Notice of AGM
24th Mar 202311:06 amRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSResults for the year ended 31 December 2022
1st Mar 20231:08 pmRNSDirectorate Change
6th Feb 20237:00 amRNSIFRS 17 UPDATE
26th Jan 20237:00 amRNSBUSINESS UPDATE FOR THE YEAR ENDED 31 DEC 2022
5th Jan 202310:19 amRNSDirectorate Change
9th Dec 202212:15 pmRNSDirector/PDMR Shareholding
1st Dec 20221:32 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.